CSL Ltd.

CSL Ltd. ADR
Stock Exchange Other OTC
EPS
$1.98
Market Cap
$71.15 B
Shares Outstanding
906.28 M
Public Float
-
CSL Ltd.
Stock Exchange Other OTC
EPS
$3.97
Market Cap
$71.72 B
Shares Outstanding
452.68 M
Public Float
-
CSL Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD5.37
Market Cap
AUD101.8 B
Shares Outstanding
453.14 M
Public Float
451.15 M
CSL Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
452.68 M
Public Float
-

Profile

Address
45 Poplar Road
Parkville Victoria (VIC) 3052
Australia
Employees -
Website http://www.csl.com.au
Updated 07/08/2019
CSL Ltd. is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma.

Financials

View All

John Shine
Chairman
Paul Roger Perreault
Chief Executive Officer, Executive Director & MD